Mentari Therapeutics secures $200 million in a private placement to further its migraine prevention pipeline, backed by leading healthcare investors.
Amount Raised
$200 Million
Round Type
Post-IPO Equity
San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Mentari Therapeutics has announced a $200 million private placement to support the development of its pipeline for migraine prevention. The funding will facilitate the continued advancement of targeted biologics. Jefferies, TD Cowen, Stifel, and Guggenheim Securities are acting as the placement agents. This financing aims to enhance outcomes for individuals affected by migraines.
Quick answer
Mentari Therapeutics raised $200 Million in a Post-IPO Equity round, dated July 22, 2026. Mentari Therapeutics is based in San Francisco, California, United States.
- How much did Mentari Therapeutics raise?
- Mentari Therapeutics raised $200 Million in a Post-IPO Equity round on July 22, 2026.
- What does Mentari Therapeutics do?
- Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine to deliver freedom from this debilitating and undertreated neurological condition.
- Where is Mentari Therapeutics based and how big is it?
- Mentari Therapeutics is based in San Francisco, California, United States. Fundz records about 2 employees.
- Who are the decision-makers at Mentari Therapeutics?
- Fundz holds 2 contacts at Mentari Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Mentari Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
- ZoeNCure Therapeutics Pvt. Ltd raised $2.4M (Seed) on September 3, 2026.
- NovaGo Therapeutics AG raised $30M (Series B) on September 2, 2026.
- Typewriter Therapeutics raised $56M (Series A) on September 2, 2026.
- NovaGo Therapeutics raised $30M (Series B) on September 2, 2026.
- CytoDyn raised $17M on September 1, 2026.
Who to call at Mentari Therapeutics, and when
A new round usually means Mentari Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Mentari Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mentari Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mentari Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mentari Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Mentari Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.